Preservation of Anemia Control and Weekly ESA Dosage After Conversion from PEG-Epoetin Beta to Darbepoetin Alfa in Adult Hemodialysis Patients: The TRANSFORM Study

INTRODUCTION: There is scant real-world information on switching treatment for anemia associated with chronic kidney disease (CKD) from methoxy polyethylene glycol-epoetin beta (PEG-Epo) to darbepoetin alfa (DA). TRANSFORM was a multi-center, observational study designed to describe the time course...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Adv Ther
Main Authors: Donck, Jan, Gonzalez-Tabares, Lourdes, Chanliau, Jacques, Martin, Heike, Stamatelou, Kyriaki, Manamley, Nick, Farouk, Mourad, Addison, Janet
Format: Artigo
Sprog:Inglês
Udgivet: Springer Healthcare 2014
Fag:
Original Research
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4245491/
https://ncbi.nlm.nih.gov/pubmed/25367412
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12325-014-0161-5
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker